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Abstract Thrombin is a potent mitogen for mesangial cells and 
stimulates PDGF B-chain gene expression in these cells. It also 
activates phospholipase C (PLC) resulting in an increase in cy- 
tosolic Ca 2÷ and diacylglycerol (DAG) that are the physiological 
activators of protein kinase C (PKC). Immunoprecipitation of 
specific PKC isotypes from thrombin-stimulated mesangial cells 
with subsequent measurement of their enzymatic activity shows 
activation of Ca2+-dependent PKC a and Ca2÷-independent PKC 
in a time dependent manner. Optimum activation of both of 
these isozymes was obtained at 60 minutes. PKC a activity in- 
creased 83% over basal while activity of PKC ~ increased 104%. 
Prolonged exposure of mesangial cells to phorbol myristate acetic 
acid (PMA) inhibited the enzymatic activity of PKC a but not 
PKC 5. This inhibition of PKC a had no effect on thrombin- 
induced DNA synthesis but abolished PDGF B-chain gene ex- 
pression induced by thrombin. These data provide the first evi- 
dence that PKC a activation is necessary for thrombin-induced 
PDGF B-chain gene expression but not for thrombin-induced 
DNA synthesis. 
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1. Introduction 
Activation of the coagulation pathway with thrombin pro- 
duction and fibrin deposition are features of severe vascular 
and proliferative glomerular diseases [1,2]. Through its prote- 
olytic activity, thrombin cleaves a tethered ligand and leads to 
activation of the receptor which is a member of the seven 
transmembrane spanning class of receptors linked to G-pro- 
teins [3]. Thrombin stimulates production of diacylglycerol 
(DAG) and inositol 1,4,5-tris-phosphate (lP3) resulting from 
the hydrolysis of phosphatidylinositol 4,5-biphosphate (PIP2) 
[4,5]. IP 3 stimulates intracellular mobilization of Ca z÷. These 
second messengers including DAG and Ca 2+, are known to 
activate protein kinase C (PKC) [6]. Multiple isozymes of PKC 
have been isolated by molecular cloning [6,7]. They fall into 
three groups. Group A consists of four classical PKCs (cPKC), 
c~, flI, flII, and 7 / and they are Ca2+-dependent for their enzy- 
matic activity. Group B comprises four novel PKCs (nPKC) ~, 
e, 0 and r/. Group C consists of two atypical PKC isotypes 
(aPKC), ( and 2 [6,7]. PKC isozymes in group B and C are 
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Ca2+-independent a d indeed they lack the Ca2÷-binding C2 
domain in their protein sequence [6,7]. Recently it has been 
shown that in chinese hamster embryo fibroblasts, thrombin 
promotes translocation f PKC ~ and e to the membrane from 
cytosol [8]. This observation suggests that thrombin causes 
activation of these PKC isotypes since translocation of 
PKC seems to be associated with activation of its enzymatic 
activity. 
We have previously reported that thrombin is a potent mito- 
gen for mesangial cells and that it stimulates phosphoinositide 
(PI) turnover and mobilization of intracellular Ca 2÷ in these 
cells [9]. Using immunoblot analysis, Saxena et al. reported the 
presence of PKC ~, PKC flI and ~, in rat mesangial cells [10]. 
In a separate study, Huwiler et al. showed that rat mesangial 
cells express only PKC ~ among the CaZ+-dependent isozymes. 
These authors could not detect PKC fl or y [11]. Using highly 
specific cDNA probes representing each Ca2+-dependent PKC 
isotypes and immunoprecipitation using isotype-specific anti- 
bodies followed by measurement of enzymatic activity, we iden- 
tified PKC c~ as the predominant CaZ+-dependent PKC isozyme 
in human mesangial cells. This PKC isotype was activated by 
PDGF [12]. Other groups have recently reported the presence 
of Ca2+-independent PKC ~, e and ( isotypes in mesangial 
cells [11,13]. In this report, we demonstrate that thrombin stim- 
ulates PKC c~ and PKC ( in human mesangial cells. We also 
provide the first evidence that inhibition of PKC c~ but not 
PKC ( is associated with abolition of PDGF B-chain mRNA 
expression without any effect on thrombin-induced mitogene- 
sis. 
2, Experimental 
2.1. Materials 
Purified human ~-thrombin and PMA were purchased from Sigma, 
St. Louis, MO. PKC assay kit and PKC isozyme specific antibodies 
were obtained from Gibco-BRL, Grand Island, N.Y. Protein A sepha- 
rose CL 4B was from Pharmacia, Piscataway, NJ. [y-32p]ATP (3000Ci/ 
mmol) was obtained from Dupont-NEN, Boston, MA. Western blot- 
ting kit (ECL Western blotting protocols) was purchased from Amer- 
sham. All other chemicals were analytical grade. 
2.2. Cell culture 
Normal portions of human ephrectomy samples or human kidney 
judged unsuitable for transplantation were used to prepare glomeruli 
for cell culture. Glomeruli were isolated from kidney cortex by sieving 
technique [14] and mesangial cells were cultured and characterized as 
we described previously [15]. The cells were grown in Waymouth's 
medium in the presence of 17% fetal calf serum [12] and were used 
between passage 6 and 11. The cells were made quiescent by incubation 
in serum free Waymouth's media for 48 h. Cells were incubated with 
6 x 10 -7 M PMA for 48 h to downregulate PKC. 10 -7 M PMA was 
added to study its effect on PDGF B-chain gene xpression. 
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2.3. Immunecomplex PKC assay 
This assay has been utilized for measuring activities of serine threon- 
ine kinases and tyrosine kinases [16,17]. The principle of the assay is 
to use specific antibodies, which do not inhibit the activity of the 
enzyme, to immunoprecipitate th  enzyme protein and use the bound 
protein on the immunebeads to assay the activity of the enzyme. We 
used isotype specific polyclonal antibodies raised against peptide se- 
quences present in the V3 region of PKC ~ (ala-gly-asn-lys-val-ile-ser- 
pro-ser-glu-asp-arg-arg-gln), PKC ,8 (gly-pro-lys-thr-glu-glu-lys-thr- 
ala-asn-thr-ile-ser-lys-phe-asp) and PKC y (asn-tyr-pro-leu-glu-leu-tyr- 
glu-arg-val-arg-thr-gly). For CaZ+-independent PKC e, 6 and 5, C- 
terminal peptides were used to raise the antibody. For PKC 6, a dode- 
capeptide (ser-phe-val-asn-pro-lys-tyr-glu-gln-phe-leu-glu) was used. 
For E also, a 12-mer peptide (lys-gly-phe-ser-tyr-phe-gly-glu-asp-leu- 
met-pro) was used. For PKC ( a 16-mer peptide (gly-phe-glu-tyr-ile- 
asn-pro-leu-leu-leu-ser-ala-glu-glu-ser-val) was used for immunization. 
Quiescent mesangial cells were stimulated with 5 units/ml thrombin for 
the time periods indicated. For PKC downregulation experiments, the 
cells were pretreated with 6 x 10 -7 M PMA for 48 h before the addition 
of thrombin. The cells were washed with ice cold PBS and lysed in 
homogenization buffer (20 mM Tris-HC1 pH 7.5, 0.5 mM EDTA, 0.5 
mM EGTA, 0.5% Triton X-100, 25 /~g/ml aprotinin, 25 pg/ml 
leupeptin) at 4°C for 30 min. The cell lysate was centrifuged at 
10,000 x g for 30 rain at 4°C Protein concentration i  the supernatant 
was determined using Bio-Rad protein assay reagent. Equal amounts 
of cell lysates were immunoprecipitated with different PKC isotype- 
specific antibodies as described [12]. The PKC activity in the im- 
munoprecipitates was measured using reagents purchased as a kit from 
Gibco-BRL. The details of the assay have recently been described by 
us [12]. Myelin basic protein (MBP)-derived peptide was used as a 
substrate for assaying PKC ~ and a Ser25-substituted peptide obtained 
from pseudosubstrate region of PKC ~ was used for PKC e, 6 and ~" 
[18]. It has recently been shown that this is a better substrate for 
Ca2+-independent PKC isotypes than MBP-derived substrate [18]. 
2.4. lmmunoblot analysis 
lmmunoblotting was performed as we described recently [19]. 
2.5. Measurement of DNA synthesis 
DNA synthesis was measured as [3H]thymidine incorporation 
into trichloroacetic acid insoluble material as previously described 
[121. 
2.6. RNase protection assay 
RNase protection assay was performed using radiolabeled RNA 
transcript of PDGF B chain gene encompassing exon 6 and 7. The 
detailed method is published elsewhere [20]. 
2.7. Data analysis 
The significance of the data was determined by Student's t-test. 
3. Results 
3.1. Activation of  PKC ~ and PKC ~ in mesangial cells 
Immunoprecipitation f PKC ~ from control and thrombin- 
stimulated mesangial cells followed by in vitro immune complex 
assay of PKC showed activation of this isozyme (Fig. 1A). 
Thrombin stimulated PKC a activity within 5 min (150%). Peak 
activity of 83% over basal was obtained after 60 min of stimu- 
lation. Similar immunecomplex kinase assays were performed 
with Ca2+-independent PKC 6, e and ~'. The data showed signif- 
icant stimulation of PKC ( activity (21% of basal) within 10 rain 
(Fig. 1B). The optimum activation (104% of basal) was ob- 
tained at 60 rain. No activation of PKC 6 and e were obtained 
in response to thrombin. These data demonstrate activation of 
both CaZ+-dependent PKC a and Ca2+-independent PKC ( by 
thrombin in human mesangial cells. To demonstrate the speci- 
ficities of the antibodies used in these immunoprecipitation 
experiments, we performed immunoblot experiments of human 
mesangial cell lysates in the presence and absence of immuniz- 
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Fig. 1. Activation of PKC ~ and PKC ~" in human mesangial cells. 
Quiescent cells were stimulated with 5 units/ml thrombin for different 
periods of time. 100 Bg of cell lysate was immunoprecipated with PKC 
specific and PKC ~" specific antibodies, respectively. The immunecom- 
plex PKC activity was measured using isotype specific substrate pep- 
tides as described in section 2. Mean with S.E.M. of three independent 
experiments each done in duplicate. '*' indicates that the increase is 
significant as compared to controls. Panel A, PKC a: *P < 0.02. Panel 
B, PKC ~'; *P < 0.05. 
ing PKC isotype-specific peptides. As positive control, we used 
rat brain extract which is rich in different Ca2+-dependent and 
independent PKC isotypes. The data show that the PKC 
specifc antibody recognized an 80 kDa protein, which is com- 
peted by the immunizing peptide (Fig. 2, PKC a panel, compare 
lane 1 with lane 3). The data also demonstrate the specificity 
of PKC ( antibody which recognizes a 71 kDa protein being 
competed by the ~" specific immunizing peptide (Fig. 2, PKC ( 
panel, compare lane 1 with lane 3). Specificity of PKC 6 and 
PKC e antibodies was also tested in a similar manner (data not 
shown). 
3.2. Activation of  PKC ~ is not required for thrombin-induced 
DNA synthesis 
To examine the role of PKC ~ in thrombin-induced mito- 
genesis, the enzyme was downregulated by pretreatment of 
human mesangial ceils with PMA. Thrombin-induced mito- 
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genesis was measured as the amount of [3H]thymidine incorpo- 
ration into DNA (Fig. 3A). The data show a 12-fold increase 
in DNA synthesis by thrombin in these cells. Downregulation 
of PKC in the presence of 6 × 10 -7 M PMA for 48 h did not 
have any significant effect on thrombin-induced DNA synthesis 
(Fig. 3A). To verify the downregulating effect of PMA on PKC 
isotypes, we measured the activity of PKC cz and PKC ( after 
PMA pretreatment. The data show a loss of more than 90% 
of PKC ~ activity whereas PMA pretreatment of mesangial 
cells had no effect on PKC ( activity (Fig. 3B and C). This 
observation confirms the previously published finding 
that phorbol ester does not deplete PKC ( in mesangial cells 
[211. 
3.3. Involvement of  PKC ot in thrombin-induced PDGF B chain 
mRNA expression 
PDGF B-chain gene expression is a delayed early response 
in mesangial cells. We have previously demonstrated that in 
addition to its mitogenic activity, thrombin stimulates PDGF 
B-chain mRNA expression [9]. To investigate the role of PKC 
in this process, PKC ~ was downregulated by prolonged prein- 
cubation of these cells with PMA. The cells were then stimu- 
lated with thrombin and the expression of PDGF B-chain 
mRNA was examined by RNase protection assay. The data 
show that PMA and thrombin stimulate PDGF B-chain gene 
expression (Fig. 4). Downregulation o fPKC ~ by pretreatment 
ofmesangial cells with PMA abolished the expression of PDGF 
B-chain mRNA induced by thrombin. These results indicate 
that thrombin-induced PDGF B-chain gene expression is sensi- 
tive to PKC ~ downregulation. In contrast PKC ( does not 
seem to play a role in this process since the activity of PKC ( 
is not inhibited by pretreatment of mesangial cells with PMA 
(Fig. 3C). 
4. Discussion 
In mesangial cells, the protease growth factor thrombin stim- 
ulates PDGF gene expression and mitogenesis [9]. The throm- 
bin signal transduction pathways leading to different biological 
effects are not precisely identified. Recent observations indicate 
that activation of PKC by growth factor and cytokines plays 
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Fig. 2. Specificity of PKC ~ and PKC ~ antibodies. 10/zg of human 
mesangial cell lysate (lanes 1 and 3) and 10,ug of rat brain extract (lanes 
2 and 4) were separated on SDS polyacrylamide g l, transferred to 
PVDF membrane and immunoblotted with anti-PKC a and PKC g" 
antibody in the presence and absence of the immunizing peptides as 
described in section 2. Lanes 1 and 2 are in the absence and lanes 3 and 
4 are in the presence of the competing peptide. Molecular weight mark- 
ers in kDa are shown in margins. 
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Fig. 3. (Panel A) Effect of PKC downregulation thrombin-induced 
DNA synthesis. Quiescent human mesangial cells were pretreated with 
6 × 10 -7 M PMA for 48 h before addition ofthrombin or PMA. DNA 
synthesis was measured as amount of [3H]thymidine incorporation i to 
TCA-insoluble precipitate as described in section 2. Results of three 
independent experiments each done in replicates of six wells. *P < 0.001 
vs. unstimulated. **P < 0.001 vs. PMA stimulation. (Panels B and C). 
Effect of PMA on PKC cc and PKC ( activity. Human mesangial cells 
were treated with 6 x 10 -7 M PMA for 48 h and the basal PKC a and 
PKC ( activity was measured after immunoprecipitation of the enzyme 
from 100/,tg of cell lysate with isoform specific antibodies as described 
in section 2. Cont, control. Mean of three independent experiments 
each done in quadruplicate. *P < 0.05. 
a major role in exerting their physiological effects [6,22]. In 
f~a2+ • mesangial cells both CaZ+-dependent and ,~ -independent 
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Fig. 4. Effect of PKC a downregulation thrombin-induced PDGF 
B-chain mRNA expression i human mesangial cells. The cells were 
treated with 6 x 10 -7 M PMA for 48 hours. Total RNA was isolated 
from PMA (4 hours) and thrombin (8 hours) stimulated cells and 
analyzed by RNase protection assay for PDGF B-chain message as 
described in section 2. Mspl digest of pBR322 DNA was labeled and 
used as a size marker as shown on the left margin. Two protected 
fragments of 310 and 150 bp represent the PDGF B-chain mRNA 
species. 
isotypes of PKCs are expressed [10-13,21]. The specific biolog- 
ical role of these PKC isotypes are not known. In this report 
we provide evidence that in mesangial cells, thrombin stimu- 
lates the Ca2+-dependent PKC ~ and Ca2+-independent PKC 
~'. Upregulation of PKC 0~ has been shown to be required for 
cell growth [22]. We demonstrate hat inhibition of PKC 
activity by prolonged incubation of cells with PMA which re- 
sults in downregulation f this enzyme had no effect on throm- 
bin-induced DNA synthesis n mesangial cells (Fig. 3A,B). This 
indicates that thrombin utilizes PKC o-independent signal 
transduction pathways for mitogenesis. Indeed we have re- 
cently shown that tyrosine phosphorylation is required for 
thrombin-induced DNA synthesis in mesangial cells [23]. We 
have previously shown that thrombin stimulates PI turnover to 
synthesize DAG and IP 3 [9]. The latter stimulates mobilization 
of Ca 2÷ from intracellular stores. Production of these second 
messengers is a prerequisite for activation of PKC cz. However 
activation of PKC ~ is independent of the presence of DAG and 
Ca 2÷ [18,24]. Downregulation f PKC by prolonged incubation 
of cells with PMA did not inhibit PKC ( activity in mesangial 
cells (Fig. 3C). Whether activation of PKC ~" is required for 
thrombin-induced DNA synthesis i not yet clear. 
PDGF B-chain gene induction is a known biological re- 
sponse of mesangial cells to certain mitogens including throm- 
bin [9]. The mechanism by which thrombin exerts this effect is 
not known. Previous tudies howed that activation of PKC by 
phorbol ester results in the induction of gene expression [25]. 
In the present study we demonstrate hat PMA stimulates 
PDGF B-chain gene expression and this induction isdependent 
on the activation of PKC ~ (Fig. 4). In addition, downregula- 
tion of PKC cc by prolonged incubation with PMA abolished 
thrombin-induced PDGF B-chain gene expression indicating 
the requirement of PKC ~ for this effect of thrombin (Fig. 4). 
Since PKC ~" activity is unchanged under these conditions (Fig. 
3C), we conclude that thrombinmediated activation of this 
isozyme of PKC is not sufficient for induction of PDGF-B- 
chain mRNA expression. These data demonstrate hat activa- 
tion of different PKC isotypes even in the same cell regulates 
specific biological response to agonist. Taken together, these 
data indicate that PKC cc and PKC ~" are the downstream target 
molecules for thrombin-mediated signal transduction pathways 
in mesangial cells and that PKC a regulates the expression of 
PDGF B-chain gene. Further studies will be necessary to ex- 
plore a direct link between mitogenesis and activation of PKC 
~" in mesangial cells. 
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